IMMULOGIC Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMMULOGIC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Michael Collins who wrote (42)	9/17/1996 4:28:00 PM
From: Rudy Saucillo	of 305

Greetings, Michael I'm also a follower of IMUL and think they're currently very undervalued. I spoke with Susan Primrose (Director of Immulogic Investor Relations) 2 weeks ago and she informed me that no decision has been made regarding another Cat trial. Their discussions with the FDA are still ongoing. My impression is that the market has already discounted that another trial will be necessary. Susan mentioned that IMUL is anticipating the following milestones in the near future: 4th Qtr 96: IND filing and initiation of Phase I trials for their MS therapy 4th Qtr 96 - 1st Qtr 97: Announcement of a new Allervax partnership 1st Qtr 97: Publication of Ragweed Phase III results and PLA filing Year end 96 - 2nd Qtr 97: PLA filing for Cat 2nd Qtr 96 - 4th Qtr 97: IND filing and initiation of Phase I trials for their cocaine vaccine CY97: Possible announcement of a corporate partnership for their contact hypersensitivity program I think the big news will be the new Allervax partnership. A strong partnership and we're off to the races! Cheers! Rudy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next